Antibody-based bio-nanotube membranes for enantiomeric drug separations

被引:586
|
作者
Lee, SB
Mitchell, DT
Trofin, L
Nevanen, TK
Söderlund, H
Martin, CR [1 ]
机构
[1] Univ Florida, Dept Chem, Gainesville, FL 32611 USA
[2] Univ Florida, Ctr Res BioNano Interface, Gainesville, FL 32611 USA
[3] VTT Biotechnol, FIN-02044 Espoo, Finland
关键词
D O I
10.1126/science.1071396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Synthetic bio-nanotube membranes were developed and used to separate two enantiomers of a chiral drug. These membranes are based on alumina films that have cylindrical pores with monodisperse nanoscopic diameters (for example, 20 nanometers). Silica nanotubes were chemically synthesized within the pores of these films, and an antibody that selectively binds one of the enantiomers of the drug was attached to the inner walls of the silica nanotubes. These membranes selectively transport the enantiomer that specifically binds to the antibody, relative to the enantiomer that has lower affinity for the antibody. The solvent dimethyl sulfoxide was used to tune the antibody binding affinity. The enantiomeric selectivity coefficient increases as the inside diameter of the silica nanotubes decreases.
引用
收藏
页码:2198 / 2200
页数:4
相关论文
共 36 条
  • [1] Molecularly Imprinted Bio-Membranes Based on Cellulose Nano-Fibers for Drug Release and Selective Separations
    Dima, Stefan-Ovidiu
    Dobre, Tanase
    Stoica-Guzun, Anicuta
    Oancea, Florin
    Jinga, Sorin-Ion
    Nicolae, Cristian-Andi
    [J]. MACROMOLECULAR SYMPOSIA, 2016, 359 (01) : 124 - 128
  • [2] Antibody-Based Therapy in AML: Antibody-Drug Conjugates and Bispecific Agents
    Fathi, Amir T.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S112 - S113
  • [3] Enantiomeric separation of antidepressant drug fluoxetine based on chiral membranes
    Salgin, Sema
    Salgin, Ugur
    Tuzlali, Nagihan
    [J]. DESALINATION AND WATER TREATMENT, 2018, 105 : 245 - 249
  • [4] Antibody-Based Molecular Communication for Targeted Drug Delivery Systems
    Chahibi, Youssef
    Akyildiz, Ian F.
    Song, Sang Ok
    [J]. 2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2014, : 5707 - 5710
  • [5] Antibody-based validation of CNS ion channel drug targets
    Rhodes, Kenneth J.
    Trimmer, James S.
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 2008, 131 (05): : 407 - 413
  • [6] MONOCLONAL ANTIBODY-BASED ELISA FOR BENZIMIDAZOLE DRUG AND PESTICIDE-RESIDUES
    BRANDON, DL
    BINDER, RG
    BATES, AH
    MONTAGUE, WC
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 152 - AGRO
  • [7] Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery
    Ghosh, Saikat
    Huda, Pie
    Fletcher, Nicholas L.
    Howard, Christopher B.
    Walsh, Bradley
    Campbell, Douglas
    Pinkham, Mark B.
    Thurecht, Kristofer J.
    [J]. MOLECULAR PHARMACEUTICS, 2022, 19 (05) : 1233 - 1247
  • [8] Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects
    Chen, Zhoujiang
    Kankala, Ranjith Kumar
    Yang, Zhiyong
    Li, Wei
    Xie, Songzhi
    Li, Hanmei
    Chen, Ai-Zheng
    Zou, Liang
    [J]. THERANOSTICS, 2022, 12 (07): : 3719 - 3746
  • [9] Functional nanotube membranes for hydrophobicity-based separations by initiated chemical vapor deposition (iCVD)
    Asatekin, Ayse
    Gleason, Karen K.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [10] Antibody-based drug delivery systems for cancer therapy: Mechanisms, challenges, and prospects
    Chen, Zhoujiang
    Kankala, Ranjith Kumar
    Yang, Zhiyong
    Li, Wei
    Xie, Songzhi
    Li, Hanmei
    Chen, Ai-Zheng
    Zou, Liang
    [J]. THERANOSTICS, 2022, 12 (08): : 3719 - 3746